Financhill
Sell
35

NNOX Quote, Financials, Valuation and Earnings

Last price:
$2.65
Seasonality move :
-14.06%
Day range:
$2.58 - $2.75
52-week range:
$2.11 - $6.42
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.59x
P/B ratio:
1.11x
Volume:
1.1M
Avg. volume:
1.2M
1-year change:
-56.05%
Market cap:
$173.3M
Revenue:
$11.3M
EPS (TTM):
-$0.88

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
NNOX
Nano-X Imaging Ltd.
$4M -$0.15 33.13% -35.84% $7.40
ICCM
IceCure Medical Ltd.
$1.3M -$0.04 196.97% -49.43% $3.13
LAB
Standard BioTools, Inc.
$18.5M -$0.03 -56.37% -70.93% $1.55
LUDG
Ludwig Enterprises, Inc.
-- -- -- -- --
XYLO
Xylo Technologies Ltd.
-- -- -- -- $9.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
NNOX
Nano-X Imaging Ltd.
$2.65 $7.40 $173.3M -- $0.00 0% 13.59x
ICCM
IceCure Medical Ltd.
$0.65 $3.13 $44.9M -- $0.00 0% 13.17x
LAB
Standard BioTools, Inc.
$1.06 $1.55 $407.6M -- $0.00 0% 3.82x
LUDG
Ludwig Enterprises, Inc.
$0.0349 -- $5.7M -- $0.00 0% 58,635.39x
XYLO
Xylo Technologies Ltd.
$5.07 $9.00 $6.5M -- $3.94 0% 0.13x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
NNOX
Nano-X Imaging Ltd.
4.79% 1.552 3.26% 3.82x
ICCM
IceCure Medical Ltd.
3% -0.312 0.41% 1.76x
LAB
Standard BioTools, Inc.
6.77% 0.460 6.26% 1.86x
LUDG
Ludwig Enterprises, Inc.
-144.65% 0.332 24.05% 0.00x
XYLO
Xylo Technologies Ltd.
29.91% -1.899 154.75% 0.95x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
NNOX
Nano-X Imaging Ltd.
-$3M -$14.2M -31.33% -32.75% -412.88% -$13.9M
ICCM
IceCure Medical Ltd.
$277K -$3.8M -195.32% -217.45% -451.29% -$3.1M
LAB
Standard BioTools, Inc.
$10.2M -$21.9M -13.22% -14.14% -92.14% -$1.7M
LUDG
Ludwig Enterprises, Inc.
-- -$371.4K -- -- -419868.12% -$139.1K
XYLO
Xylo Technologies Ltd.
-- -- -40.15% -51.7% -- --

Nano-X Imaging Ltd. vs. Competitors

  • Which has Higher Returns NNOX or ICCM?

    IceCure Medical Ltd. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of -454%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat IceCure Medical Ltd.'s return on equity of -217.45%.

    Company Gross Margin Earnings Per Share Invested Capital
    NNOX
    Nano-X Imaging Ltd.
    -86.42% -$0.21 $164.6M
    ICCM
    IceCure Medical Ltd.
    32.59% -$0.06 $9.6M
  • What do Analysts Say About NNOX or ICCM?

    Nano-X Imaging Ltd. has a consensus price target of $7.40, signalling upside risk potential of 179.25%. On the other hand IceCure Medical Ltd. has an analysts' consensus of $3.13 which suggests that it could grow by 379.81%. Given that IceCure Medical Ltd. has higher upside potential than Nano-X Imaging Ltd., analysts believe IceCure Medical Ltd. is more attractive than Nano-X Imaging Ltd..

    Company Buy Ratings Hold Ratings Sell Ratings
    NNOX
    Nano-X Imaging Ltd.
    4 0 0
    ICCM
    IceCure Medical Ltd.
    1 0 0
  • Is NNOX or ICCM More Risky?

    Nano-X Imaging Ltd. has a beta of 1.383, which suggesting that the stock is 38.349% more volatile than S&P 500. In comparison IceCure Medical Ltd. has a beta of 0.903, suggesting its less volatile than the S&P 500 by 9.66%.

  • Which is a Better Dividend Stock NNOX or ICCM?

    Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IceCure Medical Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. IceCure Medical Ltd. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NNOX or ICCM?

    Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are larger than IceCure Medical Ltd. quarterly revenues of $850K. Nano-X Imaging Ltd.'s net income of -$13.7M is lower than IceCure Medical Ltd.'s net income of -$3.9M. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while IceCure Medical Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 13.59x versus 13.17x for IceCure Medical Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NNOX
    Nano-X Imaging Ltd.
    13.59x -- $3.4M -$13.7M
    ICCM
    IceCure Medical Ltd.
    13.17x -- $850K -$3.9M
  • Which has Higher Returns NNOX or LAB?

    Standard BioTools, Inc. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of 58.42%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat Standard BioTools, Inc.'s return on equity of -14.14%.

    Company Gross Margin Earnings Per Share Invested Capital
    NNOX
    Nano-X Imaging Ltd.
    -86.42% -$0.21 $164.6M
    LAB
    Standard BioTools, Inc.
    43.03% $0.05 $455.1M
  • What do Analysts Say About NNOX or LAB?

    Nano-X Imaging Ltd. has a consensus price target of $7.40, signalling upside risk potential of 179.25%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.55 which suggests that it could grow by 46.23%. Given that Nano-X Imaging Ltd. has higher upside potential than Standard BioTools, Inc., analysts believe Nano-X Imaging Ltd. is more attractive than Standard BioTools, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    NNOX
    Nano-X Imaging Ltd.
    4 0 0
    LAB
    Standard BioTools, Inc.
    1 2 0
  • Is NNOX or LAB More Risky?

    Nano-X Imaging Ltd. has a beta of 1.383, which suggesting that the stock is 38.349% more volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.359, suggesting its more volatile than the S&P 500 by 35.922%.

  • Which is a Better Dividend Stock NNOX or LAB?

    Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NNOX or LAB?

    Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are smaller than Standard BioTools, Inc. quarterly revenues of $23.8M. Nano-X Imaging Ltd.'s net income of -$13.7M is lower than Standard BioTools, Inc.'s net income of $13.9M. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 13.59x versus 3.82x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NNOX
    Nano-X Imaging Ltd.
    13.59x -- $3.4M -$13.7M
    LAB
    Standard BioTools, Inc.
    3.82x -- $23.8M $13.9M
  • Which has Higher Returns NNOX or LUDG?

    Ludwig Enterprises, Inc. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of -427991.3%. Nano-X Imaging Ltd.'s return on equity of -32.75% beat Ludwig Enterprises, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    NNOX
    Nano-X Imaging Ltd.
    -86.42% -$0.21 $164.6M
    LUDG
    Ludwig Enterprises, Inc.
    -- -- -$1.4M
  • What do Analysts Say About NNOX or LUDG?

    Nano-X Imaging Ltd. has a consensus price target of $7.40, signalling upside risk potential of 179.25%. On the other hand Ludwig Enterprises, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Nano-X Imaging Ltd. has higher upside potential than Ludwig Enterprises, Inc., analysts believe Nano-X Imaging Ltd. is more attractive than Ludwig Enterprises, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    NNOX
    Nano-X Imaging Ltd.
    4 0 0
    LUDG
    Ludwig Enterprises, Inc.
    0 0 0
  • Is NNOX or LUDG More Risky?

    Nano-X Imaging Ltd. has a beta of 1.383, which suggesting that the stock is 38.349% more volatile than S&P 500. In comparison Ludwig Enterprises, Inc. has a beta of 2.693, suggesting its more volatile than the S&P 500 by 169.348%.

  • Which is a Better Dividend Stock NNOX or LUDG?

    Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ludwig Enterprises, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. Ludwig Enterprises, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NNOX or LUDG?

    Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are larger than Ludwig Enterprises, Inc. quarterly revenues of --. Nano-X Imaging Ltd.'s net income of -$13.7M is lower than Ludwig Enterprises, Inc.'s net income of $31.3K. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while Ludwig Enterprises, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 13.59x versus 58,635.39x for Ludwig Enterprises, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NNOX
    Nano-X Imaging Ltd.
    13.59x -- $3.4M -$13.7M
    LUDG
    Ludwig Enterprises, Inc.
    58,635.39x -- -- $31.3K
  • Which has Higher Returns NNOX or XYLO?

    Xylo Technologies Ltd. has a net margin of -396.98% compared to Nano-X Imaging Ltd.'s net margin of --. Nano-X Imaging Ltd.'s return on equity of -32.75% beat Xylo Technologies Ltd.'s return on equity of -51.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    NNOX
    Nano-X Imaging Ltd.
    -86.42% -$0.21 $164.6M
    XYLO
    Xylo Technologies Ltd.
    -- -- $22.4M
  • What do Analysts Say About NNOX or XYLO?

    Nano-X Imaging Ltd. has a consensus price target of $7.40, signalling upside risk potential of 179.25%. On the other hand Xylo Technologies Ltd. has an analysts' consensus of $9.00 which suggests that it could grow by 77.52%. Given that Nano-X Imaging Ltd. has higher upside potential than Xylo Technologies Ltd., analysts believe Nano-X Imaging Ltd. is more attractive than Xylo Technologies Ltd..

    Company Buy Ratings Hold Ratings Sell Ratings
    NNOX
    Nano-X Imaging Ltd.
    4 0 0
    XYLO
    Xylo Technologies Ltd.
    1 0 0
  • Is NNOX or XYLO More Risky?

    Nano-X Imaging Ltd. has a beta of 1.383, which suggesting that the stock is 38.349% more volatile than S&P 500. In comparison Xylo Technologies Ltd. has a beta of 0.273, suggesting its less volatile than the S&P 500 by 72.733%.

  • Which is a Better Dividend Stock NNOX or XYLO?

    Nano-X Imaging Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xylo Technologies Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $3.94 per share. Nano-X Imaging Ltd. pays -- of its earnings as a dividend. Xylo Technologies Ltd. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NNOX or XYLO?

    Nano-X Imaging Ltd. quarterly revenues are $3.4M, which are larger than Xylo Technologies Ltd. quarterly revenues of --. Nano-X Imaging Ltd.'s net income of -$13.7M is higher than Xylo Technologies Ltd.'s net income of --. Notably, Nano-X Imaging Ltd.'s price-to-earnings ratio is -- while Xylo Technologies Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nano-X Imaging Ltd. is 13.59x versus 0.13x for Xylo Technologies Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NNOX
    Nano-X Imaging Ltd.
    13.59x -- $3.4M -$13.7M
    XYLO
    Xylo Technologies Ltd.
    0.13x -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
42
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
93
NBTX alert for Mar 5

Nanobiotix SA [NBTX] is down 5.37% over the past day.

Sell
45
MRNA alert for Mar 5

Moderna, Inc. [MRNA] is down 1.02% over the past day.

Buy
77
SSRM alert for Mar 5

SSR Mining, Inc. [SSRM] is down 6.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock